Bioavailability Containment Medicine 
XTalks
DECEMBER 5, 2022
Clinical-stage biotech company PureTech Health has announced it has developed a new oral CBD therapeutic candidate with improved bioavailability and tolerability, which could expand use of the CBD prodrug in a wide range of indications and age groups. Epidiolex contains sesame seed oil, restricting its use for some individuals.
Pharmaceutical Technology
NOVEMBER 24, 2022
The number of commercially available 14 C-labeled starting materials is limited, and unlike the medicinal chemistry or process chemistry routes, we are restricted to a few very simple building blocks. This has proved to be an extremely effective option for molecules where an understanding of absolute bioavailability is required.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Pharmaceutical Technology
AUGUST 3, 2022
Today, they are still thought to represent approximately two-thirds of all medicines administered through prescription and over-the-counter. Due to the toxicity of many active ingredients used in pharmaceutical manufacturing, some processes may require containment to prevent operator exposure to hazardous, potent chemicals.
The Pharma Data
DECEMBER 29, 2020
Cybin is developing technologies and delivery systems, aiming to improve bioavailability, to potentially achieve the desired medicinal effects of psychedelics at low dosage levels. Cybin is a life sciences company advancing psychedelic pharmaceutical treatments for various psychiatric and neurological conditions.
The Pharma Data
NOVEMBER 26, 2020
This novel nanoparticle formation technology provides hope for improving the possibilities and probabilities of developing better medicines for patients and it expands Nanoform’s reach into the growing biological market. Nanoform is an innovative nanoparticle medicine enabling company. HELSINKI , Nov. Finnish time.
The Pharma Data
JANUARY 3, 2021
4, 2021 /PRNewswire/ — Nanoform Finland Plc (“Nanoform”), an innovative nanoparticle medicine enabling company, today announced a new near-term business target. Nanoform is an innovative nanoparticle medicine enabling company. HELSINKI , Jan. Finnish time. About Nanoform. For more information please visit [link].
The Pharma Data
DECEMBER 8, 2020
Nasdaq: KURA), a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer, today announced the pricing of an underwritten public offering of 8,110,000 shares of its common stock at a price to the public of $37.00 SAN DIEGO, Dec. About Kura Oncology.
Expert insights. Personalized for you.
97 
Let's personalize your content